152 related articles for article (PubMed ID: 16980199)
21. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
22. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
23. Arterial stiffness and insulin resistance.
Westerbacka J; Yki-Järvinen H
Semin Vasc Med; 2002 May; 2(2):157-64. PubMed ID: 16222607
[TBL] [Abstract][Full Text] [Related]
24. Optimizing cardiovascular outcomes in diabetes mellitus.
Sobel BE
Am J Med; 2007 Sep; 120(9 Suppl 2):S3-11. PubMed ID: 17826044
[TBL] [Abstract][Full Text] [Related]
25. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
27. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome: are we at risk?
Paudel B
Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
[TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of physical exercise for diabetes/metabolic syndrome.
Sato Y; Nagasaki M; Kubota M; Uno T; Nakai N
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S87-91. PubMed ID: 17498834
[TBL] [Abstract][Full Text] [Related]
30. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
Abbasi F; Lima NK; Reaven GM
Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
[TBL] [Abstract][Full Text] [Related]
31. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
[TBL] [Abstract][Full Text] [Related]
32. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
34. Low-intensity voluntary running lowers blood pressure with simultaneous improvement in endothelium-dependent vasodilatation and insulin sensitivity in aged spontaneously hypertensive rats.
Sun MW; Qian FL; Wang J; Tao T; Guo J; Wang L; Lu AY; Chen H
Hypertens Res; 2008 Mar; 31(3):543-52. PubMed ID: 18497475
[TBL] [Abstract][Full Text] [Related]
35. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
36. Gestational diabetes, pregnancy hypertension, and late vascular disease.
Carpenter MW
Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome and the menopause.
Kaaja RJ
Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
[TBL] [Abstract][Full Text] [Related]
38. Lifestyle, cardio-metabolic risk and arterial stiffness.
Duda-Seiman DM; Mancaş S; Gaită D; Drăgan S; Velimirovici D; Iurciuc S; Sarău CA; Iurciuc M; Rada M; Petcov B
Rom J Intern Med; 2008; 46(1):39-45. PubMed ID: 19157269
[TBL] [Abstract][Full Text] [Related]
39. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
Burgert TS; Duran EJ; Goldberg-Gell R; Dziura J; Yeckel CW; Katz S; Tamborlane WV; Caprio S
Pediatr Diabetes; 2008 Dec; 9(6):567-76. PubMed ID: 18761646
[TBL] [Abstract][Full Text] [Related]
40. The effects of exercise training on insulin resistance in patients with coronary artery disease.
Suskin NG; Heigenhauser G; Afzal R; Finegood D; Gerstein HC; McKelvie RS
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):803-8. PubMed ID: 18043303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
